Stockreport

Dianthus Therapeutics, Inc. Announces Pricing of Upsized $251 Million Underwritten Public Offering [Yahoo! Finance]

Dianthus Therapeutics, Inc.  (DNTH) 
PDF NEW YORK and WALTHAM, Mass., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancin [Read more]